Nelarabine May Be Safely Incorporated Into a Phase III Study for Newly Diagnosed T-Lineage Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group

被引：0
|
作者：
Winter, Stuart S. [1 ]
Devidas, Meenakshi [2 ]
Wood, Brent [3 ]
Borowitz, Michael J. [4 ]
Loh, Mignon L. [5 ]
Asselin, Barbara [6 ]
Murphy, John [7 ]
Raetz, Elizabeth [8 ]
Winick, Naomi [9 ]
Hunger, Stephen [10 ]
Carroll, William [8 ]
Dunsmore, Kimberly [11 ]
机构：
[1] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA
[2] Univ Florida, Coll Med, Dept Biostat, Gainesville, FL USA
[3] Seattle Canc Care Alliance, Seattle, WA USA
[4] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA
[5] Univ Calif San Francisco, Div Pediat Hematol Oncol, San Francisco, CA 94143 USA
[6] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[7] Princess Margaret Hosp Children, Perth, WA, Australia
[8] NYU, Langone Med Ctr, New York, NY USA
[9] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[10] Univ Colorado, Coll Med, Pediat Hem Onc BMT, Aurora, CO USA
[11] Univ Virginia, Charlottesville, VA USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：378 / 378
页数：1
相关论文
共 50 条
  • [1] Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia
    Dunsmore, Kimberly P.
    Winter, Stuart S.
    Devidas, Meenakshi
    Wood, Brent L.
    Esiashvili, Natia
    Chen, Zhiguo
    Eisenberg, Nancy
    Briegel, Nikki
    Hayashi, Robert J.
    Gastier-Foster, Julie M.
    Carroll, Andrew J.
    Heerema, Nyla A.
    Asselin, Barbara L.
    Rabin, Karen R.
    Zweidler-Mckay, Patrick A.
    Raetz, Elizabeth A.
    Loh, Mignon L.
    Schultz, Kirk R.
    Winick, Naomi J.
    Carroll, William L.
    Hunger, Stephen P.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (28) : 3282 - 3293
  • [2] Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group
    Winter, Stuart S.
    Jiang, Zeyu
    Khawaja, Hadya M.
    Griffin, Timothy
    Devidas, Meenakshi
    Asselin, Barbara L.
    Larson, Richard S.
    BLOOD, 2007, 110 (05) : 1429 - 1438
  • [3] Safety and efficacy of nelarabine in children and young adults with relapsed or refractory T-lineage acute lymphoblastic leukaemia or T-lineage lymphoblastic lymphoma: results of a phase 4 study
    Zwaan, Christian Michel
    Kowalczyk, Jerzy
    Schmitt, Claudine
    Bielorai, Bella
    Russo, Mark W.
    Woessner, Mary
    Ranganathan, Sulabha
    Leverger, Guy
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 179 (02) : 284 - 293
  • [4] Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434
    Winter, Stuart S.
    Dunsmore, Kimberly P.
    Devidas, Meenakshi
    Eisenberg, Nancy
    Asselin, Barbara L.
    Wood, Brent L.
    Leonard, Marcia S.
    Murphy, John
    Gastier-Foster, Julie M.
    Carroll, Andrew J.
    Heerema, Nyla A.
    Loh, Mignon L.
    Raetz, Elizabeth A.
    Winick, Naomi J.
    Carroll, William L.
    Hunger, Stephen P.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (07) : 1176 - 1183
  • [5] MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group Study
    Matlawska-Wasowska, K.
    Kang, H.
    Devidas, M.
    Wen, J.
    Harvey, R. C.
    Nickl, C. K.
    Ness, S. A.
    Rusch, M.
    Li, Y.
    Onozawa, M.
    Martinez, C.
    Wood, B. L.
    Asselin, B. L.
    Chen, I-M
    Roberts, K. G.
    Baruchel, A.
    Soulier, J.
    Dombret, H.
    Zhang, J.
    Larson, R. S.
    Raetz, E. A.
    Carroll, W. L.
    Winick, N. J.
    Aplan, P. D.
    Loh, M. L.
    Mullighan, C. G.
    Hunger, S. P.
    Heerema, N. A.
    Carroll, A. J.
    Dunsmore, K. P.
    Winter, S. S.
    LEUKEMIA, 2016, 30 (09) : 1909 - 1912
  • [6] MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children’s Oncology Group Study
    K Matlawska-Wasowska
    H Kang
    M Devidas
    J Wen
    R C Harvey
    C K Nickl
    S A Ness
    M Rusch
    Y Li
    M Onozawa
    C Martinez
    B L Wood
    B L Asselin
    I-M Chen
    K G Roberts
    A Baruchel
    J Soulier
    H Dombret
    J Zhang
    R S Larson
    E A Raetz
    W L Carroll
    N J Winick
    P D Aplan
    M L Loh
    C G Mullighan
    S P Hunger
    N A Heerema
    A J Carroll
    K P Dunsmore
    S S Winter
    Leukemia, 2016, 30 : 1909 - 1912
  • [7] Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801
    DeAngelo, Daniel J.
    Yu, Daohai
    Johnson, Jeffrey L.
    Coutre, Steven E.
    Stone, Richard M.
    Stopeck, Alison T.
    Gockerman, Jon P.
    Mitchell, Beverly S.
    Appelbaum, Frederick R.
    Larson, Richard A.
    BLOOD, 2007, 109 (12) : 5136 - 5142
  • [8] Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: A report from the children's cancer group
    Heerema, NA
    Sather, HN
    Sensel, MG
    Kraft, P
    Nachman, JB
    Steinherz, PG
    Lange, BJ
    Hutchinson, RS
    Reaman, GH
    Trigg, ME
    Arthur, DC
    Gaynon, PS
    Uckun, FM
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1270 - 1278
  • [9] Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology Group (vol 110, pg 1429, 2007)
    Winter, S. S.
    Jiang, Z.
    Khawaja, H. M.
    Griffin, T.
    Devidas, M.
    Asselin, B. L.
    Larson, R. S.
    BLOOD, 2008, 111 (09) : 4830 - 4830
  • [10] Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: A Children's Cancer Group study
    Uckun, FM
    Reaman, G
    Steinherz, PG
    Arthur, DC
    Sather, H
    Trigg, M
    Tubergen, D
    Gaynon, P
    LEUKEMIA & LYMPHOMA, 1996, 24 (1-2) : 57 - 70
12345